These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3172131)

  • 21. Bioactive conformation of 1-arylpiperazines at central serotonin receptors.
    Huff JR; King SW; Saari WS; Springer JP; Martin GE; Williams M
    J Med Chem; 1985 Jul; 28(7):945-8. PubMed ID: 4009617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards metabolically stable 5-HT7 receptor ligands: a study on 1-arylpiperazine derivatives and related isosters.
    Lacivita E; De Giorgio P; Patarnello D; Niso M; Colabufo NA; Berardi F; Perrone R; Satala G; Duszynska B; Bojarski AJ; Leopoldo M
    Exp Brain Res; 2013 Oct; 230(4):569-82. PubMed ID: 23571499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure-activity relationships of a new model of arylpiperazines. 1. 2-[[4-(o-methoxyphenyl)piperazin-1-yl]methyl]-1, 3-dioxoperhydroimidazo[1,5-alpha]pyridine: a selective 5-HT1A receptor agonist.
    López-Rodríguez ML; Rosado ML; Benhamú B; Morcillo MJ; Sanz AM; Orensanz L; Beneitez ME; Fuentes JA; Manzanares J
    J Med Chem; 1996 Oct; 39(22):4439-50. PubMed ID: 8893838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-affinity relationship studies on 5-HT1A receptor ligands. 2. Heterobicyclic phenylpiperazines with N4-aralkyl substituents.
    van Steen BJ; van Wijngaarden I; Tulp MT; Soudijn W
    J Med Chem; 1994 Aug; 37(17):2761-73. PubMed ID: 8064803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR.
    Intagliata S; Modica MN; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Romeo G
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4052-6. PubMed ID: 27396505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
    López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
    J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
    Peglion JL; Canton H; Bervoets K; Audinot V; Brocco M; Gobert A; Le Marouille-Girardon S; Millan MJ
    J Med Chem; 1995 Sep; 38(20):4044-55. PubMed ID: 7562940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and structure-activity relationships of a new model of arylpiperazines. 2. Three-dimensional quantitative structure-activity relationships of hydantoin-phenylpiperazine derivatives with affinity for 5-HT1A and alpha 1 receptors. A comparison of CoMFA models.
    López-Rodríguez ML; Rosado ML; Benhamú B; Morcillo MJ; Fernández E; Schaper KJ
    J Med Chem; 1997 May; 40(11):1648-56. PubMed ID: 9171874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT₁A and 5-HT₇ receptor ligands.
    Modica MN; Intagliata S; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Romeo G
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1427-30. PubMed ID: 25759032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the amide fragment on 5-HT1A receptor activity of some analogs of MP 3022.
    Paluchowska MH; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A
    Pol J Pharmacol; 1999; 51(5):415-21. PubMed ID: 10817542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.
    Glennon RA; Hong SS; Bondarev M; Law H; Dukat M; Rakhi S; Power P; Fan E; Kinneau D; Kamboj R; Teitler M; Herrick-Davis K; Smith C
    J Med Chem; 1996 Jan; 39(1):314-22. PubMed ID: 8568822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationship studies of central nervous system agents. 5. Effect of the hydrocarbon chain on the affinity of 4-substituted 1-(3-chlorophenyl)piperazines for 5-HT1A receptor site.
    Mokrosz JL; Pietrasiewicz M; Duszyńska B; Cegła MT
    J Med Chem; 1992 Jun; 35(13):2369-74. PubMed ID: 1535661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and structure-activity relationships of a new model of arylpiperazines. 3.1 2-[omega-(4-arylpiperazin-1-yl)alkyl]perhydropyrrolo- [1,2-c]imidazoles and -perhydroimidazo[1,5-a]pyridines: study of the influence of the terminal amide fragment on 5-HT1A affinity/selectivity.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Murcia M; Sanz AM; Orensanz L
    J Med Chem; 1997 Aug; 40(16):2653-6. PubMed ID: 9258372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
    Naiman N; Lyon RA; Bullock AE; Rydelek LT; Titeler M; Glennon RA
    J Med Chem; 1989 Jan; 32(1):253-6. PubMed ID: 2521252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of spacer structure on 5-HT7 and 5-HT1A receptor affinity in the group of long-chain arylpiperazine ligands.
    Bojarski AJ; Duszyńska B; Kołaczkowski M; Kowalski P; Kowalska T
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5863-6. PubMed ID: 15501057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and in vitro pharmacological evaluation of novel 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands.
    Fiorino F; Magli E; Severino B; Corvino A; Ciano A; Perissutti E; Frecentese F; Massarelli P; Nencini C; Santagada V; Caliendo G
    Arch Pharm (Weinheim); 2014 Oct; 347(10):698-706. PubMed ID: 25113046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1-aryl-4-[(1-tetralinyl)alkyl]piperazines: alkylamido and alkylamino derivatives. Synthesis, 5-HT1A receptor affinity, and selectivity. 3.
    Perrone R; Berardi F; Leopoldo M; Tortorella V; Fornaretto MG; Caccia C; McArthur RA
    J Med Chem; 1996 Aug; 39(16):3195-202. PubMed ID: 8759642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New N- and O-arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT
    Intagliata S; Modica MN; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Kurczab R; Romeo G
    Bioorg Med Chem; 2017 Feb; 25(3):1250-1259. PubMed ID: 28063784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of phenyl- and benzoylpiperazines as potential serotonergic agents.
    Lyon RA; Titeler M; McKenney JD; Magee PS; Glennon RA
    J Med Chem; 1986 May; 29(5):630-4. PubMed ID: 3701781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part 4.
    Herold F; Król M; Kleps J; Nowak G
    Eur J Med Chem; 2006 Jan; 41(1):125-34. PubMed ID: 16263195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.